Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on September 16, 2026

Sep. 16, 2026

MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial

Indeterminate GlobeNewswire

Sep. 16, 2026

VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

Indeterminate GlobeNewswire

Sep. 16, 2026

Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation

Indeterminate GlobeNewswire

Sep. 16, 2026

RIX Industries Partners with Build Health International to Bring Medical Oxygen Compressor Training to Africa

Indeterminate GlobeNewswire

Sep. 16, 2026

Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care

Indeterminate GlobeNewswire

Sep. 16, 2026

Rezera Announces Plans to Launch the REVEAL-PAD Multi-Center Study Investigating the Role of Inflammation in Patients with Peripheral Artery Disease

Indeterminate GlobeNewswire

Sep. 16, 2026

Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum

Indeterminate GlobeNewswire

Sep. 16, 2026

R1 Expands Phare OS with Phare UM, Bringing Real-Time Payer Risk Intelligence to Utilization Management

Indeterminate GlobeNewswire

Sep. 16, 2026

Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement

Indeterminate GlobeNewswire

Sep. 16, 2026

Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale

Indeterminate GlobeNewswire

Sep. 16, 2026

Syneos Health and Tufts CSDD Study Shows Clinical Trial Performance Depends More on Operating Model Design Than Sourcing Strategy

Indeterminate GlobeNewswire

Sep. 16, 2026

Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial

Indeterminate GlobeNewswire

Sep. 16, 2026

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Indeterminate GlobeNewswire

Sep. 16, 2026

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®

Indeterminate GlobeNewswire

Sep. 16, 2026

Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

Indeterminate GlobeNewswire

Sep. 16, 2026

Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

Indeterminate GlobeNewswire

Sep. 16, 2026

Ennature Biopharma Advances Women’s Health Science With Fast-Acting Shatavari and Sustained-Release Ginger

Indeterminate GlobeNewswire

Sep. 16, 2026

Coave Therapeutics Strengthens Leadership Team to Advance Lead Gene Therapy Program into the Clinic

Indeterminate GlobeNewswire

Sep. 16, 2026

Shock Top and Spirit Halloween Brew Up a Scary Good Collaboration

Indeterminate GlobeNewswire

Sep. 16, 2026

Sironax Announces Option Exercise and Asset Purchase

Indeterminate GlobeNewswire